羊毛克拉/泽奥利特伊米达酸框架-8复合形状记忆海绵,具有协同静血性能,可快速控制出血
Feng Sang1,2, Xiao Yang1, Jiahui Hao1,2
1Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325011, China. shicc@ucas.ac.cn.
Journal of materials chemistry. B
|October 23, 2023
概括
一种新型的羊毛氨酸/化物伊米达酸框架-8 (WK/ZIF-8) 复合海绵有效地阻止大规模出血并预防感染. 这种先进的伤口带显示出卓越的止血和抗菌特性,可以改善愈合.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 无法控制的出血和伤口感染是危及生命的,特别是深度,不可压缩的出血.
- 现有的治疗方法在控制严重出血和预防后续感染方面面临挑战.
- 需要先进的伤口护理材料来解决这些关键的医疗问题.
研究的目的:
- 开发和评估一种新型的羊毛氨酸/地质化伊米达酸框架-8 (WK/ZIF-8) 复合形状记忆海绵.
- 评估WK/ZIF-8复合海绵的静血和抗菌能力.
- 在临床前模型中,比较WK/ZIF-8复合海绵与商业医疗海绵的性能.
主要方法:
- 制造WK/ZIF-8复合海绵,通过将ZIF-8纳米颗粒纳入羊毛角.
- 对复合海绵的机械性能,细胞活力影响和抗菌功效的评估.
- 在Sprague-Dawley (SD) 鼠和子出血模型中对静血性能的评估.
- 在体外和体外抗菌测试以确认抗感染活性.
主要成果:
- 与单独使用ZIF-8相比,WK/ZIF-8复合海绵表现出增强的机械性能和降低的细胞毒性.
- 在动物模型中,复合海绵表现出优越的静血性能,超过商业海绵.
- 观察到显著的体外和体外抗菌活性,表明有效的抗感染特性.
- 毛孔结构和形状恢复能力有助于海绵的静血疗效.
结论:
- WK/ZIF-8复合海绵为快速控制出血和预防感染提供了一个有前途的解决方案.
- 羊毛克拉和ZIF-8纳米颗粒之间的协同效应增强了血液静止和抗菌作用.
- 这种新型生物材料有可能推进伤口管理策略并改善患者的治疗结果.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.


